Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Liabilities and Shareholders Equity (2023 - 2025)

Profound Medical has reported Liabilities and Shareholders Equity over the past 3 years, most recently at $77.5 million for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $77.5 million for Q4 2025, up 10.31% from a year ago — trailing twelve months through Dec 2025 was $230.3 million (up 227.92% YoY), and the annual figure for FY2025 was $77.5 million, up 10.31%.
  • Liabilities and Shareholders Equity for Q4 2025 was $77.5 million at Profound Medical, up from $42.3 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for PROF hit a ceiling of $77.5 million in Q4 2025 and a floor of $42.3 million in Q3 2025.
  • Median Liabilities and Shareholders Equity over the past 3 years was $55.3 million (2025), compared with a mean of $57.4 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: surged 59.78% in 2024 and later rose 10.31% in 2025.
  • Profound Medical's Liabilities and Shareholders Equity stood at $44.0 million in 2023, then surged by 59.78% to $70.2 million in 2024, then grew by 10.31% to $77.5 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $77.5 million (Q4 2025), $42.3 million (Q3 2025), and $49.7 million (Q2 2025) per Business Quant data.